Rocket


News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Viracta Subsidiary, Inc. (VIRX) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/10/2023 SC 13D/A Schindel Yair Chaim reports a 19.4% stake in Viracta Therapeutics, Inc.
03/10/2021 D Form D - Notice of Exempt Offering of Securities:
03/03/2021 SC 13G LVP LIFE SCIENCE VENTURES III L.P. reports a 8.4% stake in Viracta Therapeutics, Inc.
03/01/2021 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:
12/10/2020 D Form D - Notice of Exempt Offering of Securities:
11/05/2019 D Form D - Notice of Exempt Offering of Securities:
02/12/2019 D Form D - Notice of Exempt Offering of Securities:
02/12/2019 D/A Form D/A - Notice of Exempt Offering of Securities: [Amend]
12/13/2018 D Form D - Notice of Exempt Offering of Securities:
07/02/2018 D Form D - Notice of Exempt Offering of Securities:
04/05/2017 D Form D - Notice of Exempt Offering of Securities
01/09/2009 REGDEX/A Form REGDEX/A -- Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933] [amend]

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy